5:47 PM
 | 
Jan 28, 2014
 |  BC Extra  |  Financial News

Dicerna, Celladon, Eagle amend IPOs

RNAi play Dicerna Pharmaceuticals Inc. (Watertown, Mass.), gene therapy company Celladon Corp. (San Diego, Calif.) and drug delivery company Eagle Pharmaceuticals Inc. (Woodcliff Lake, N.J.) all amended planned IPOs on NASDAQ. Dicerna bumped up both the number of shares and price for its IPO. The company plans to raise $84 million through the sale of 6 million shares at $14, which would value Dicerna at $232.8 million. Last week,...

Read the full 340 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >